Your browser doesn't support javascript.
loading
Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis.
Baronas, Victoria A; Arif, Arif A; Bhang, Eric; Ladua, Gale K; Brown, Carl J; Donnellan, Fergal; Gill, Sharlene; Stuart, Heather C; Loree, Jonathan M.
Afiliação
  • Baronas VA; Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Arif AA; Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Bhang E; Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Ladua GK; Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Brown CJ; Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Donnellan F; Department of Surgery, Division of General Surgery, St. Paul's Hospital, Vancouver, BC V6Z1Y6, Canada.
  • Gill S; Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Stuart HC; Division of Gastroenterology, Vancouver General Hospital, Vancouver, BC V5Z1M9, Canada.
  • Loree JM; Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
Curr Oncol ; 31(4): 2133-2144, 2024 04 08.
Article em En | MEDLINE | ID: mdl-38668061
ABSTRACT

Background:

The incidence of colorectal cancer (CRC) is decreasing in individuals >50 years due to organised screening but has increased for younger individuals. We characterized symptoms and their timing before diagnosis in young individuals.

Methods:

We identified all patients diagnosed with CRC between 1990-2017 in British Columbia, Canada. Individuals <50 years (n = 2544, EoCRC) and a matched cohort >50 (n = 2570, LoCRC) underwent chart review to identify CRC related symptoms at diagnosis and determine time from symptom onset to diagnosis.

Results:

Across all stages of CRC, EoCRC presented with significantly more symptoms than LoCRC (Stage 1 mean ± SD 1.3 ± 0.9 vs. 0.7 ± 0.9, p = 0.0008; Stage 4 3.3 ± 1.5 vs. 2.3 ± 1.7, p < 0.0001). Greater symptom burden at diagnosis was associated with worse survival in both EoCRC (p < 0.0001) and LoCRC (p < 0.0001). When controlling for cancer stage, both age (HR 0.87, 95% CI 0.8-1.0, p = 0.008) and increasing symptom number were independently associated with worse survival in multivariate models.

Conclusions:

Patients with EoCRC present with a greater number of symptoms of longer duration than LoCRC; however, time from patient reported symptom onset was not associated with worse outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Idade de Início Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Curr Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Idade de Início Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Curr Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá